论文部分内容阅读
目的:分析新生儿肺炎患者临床抗生素的使用情况。方法:选取2011年3月—2015年3月间新生儿科收治入院的新生儿肺炎患者170例临床资料,分析临床治疗中抗生素的使用情况。结果:170例肺炎患儿中,给予青霉素治疗的患者为57例,占总例百分比为33.53%;其次为氨苄青霉素39例占22.94%;再则为头孢噻肟钠28例,占16.47%;给予单用青霉素治疗的患者,其疗效显著高于其他用药方式(P<0.05);针对并发症的治疗,给予抗生素治疗中,患者出现的不同程度的过敏症状的发生率低于给予其他抗生素治疗(P<0.05)。结论:抗生素在新生儿肺炎患者的治疗中具有较高的临床使用价值,且其用药的安全性也相对较高;不同的用药方式其疗效均不相同,临床可根据患儿的病情合理选用。
Objective: To analyze the clinical use of antibiotics in neonates with pneumonia. Methods: The clinical data of 170 neonates with pneumonia admitted to the neonatology department from March 2011 to March 2015 were selected to analyze the use of antibiotics in clinical treatment. Results: Among 170 children with pneumonia, 57 patients were treated with penicillin, accounting for 33.53%; followed by ampicillin 39 (22.94%); cefotaxime sodium 28 (16.47%); In patients treated with penicillin alone, the efficacy was significantly higher than that of other modes of treatment (P <0.05). For the treatment of complications, the incidence of allergic symptoms in patients receiving antibiotics was lower than that of other antibiotics (P <0.05). Conclusions: Antibiotics has high clinical value in the treatment of neonatal pneumonia and the safety of its use is relatively high. The curative effects of different methods are different, and the clinical treatment can be properly selected according to the condition of the children.